.svg){kind=icon}
+91-9660032889
support@mysiponline.com
-
₹13.74
(-0.209%)
Current NAV 31-10-2024
-
0%
1Y Returns
-
Min. SIP ₹100
Min. Investment ₹100
Fund Suitability Test
Returns
Track investment returns to meet financial goals.
| This Fund | Category Avg. | Benchmark | |
|---|---|---|---|
| 1W | 1.29% | 0.75% | 1.15% |
| 1M | 5.82% | 1.37% | 1.1% |
| 3M | 17.7% | 7.6% | 10.09% |
| 6M | 17.39% | 12.98% | 15.09% |
| 1Y | 0% | 29.15% | 31.32% |
| 2Y | 0% | 22.65% | 20.68% |
| 3Y | 0% | 17.71% | 15.83% |
| 5Y | 0% | 19.36% | 19.17% |
| ALL | 32.82% | 17.72% | 14.4% |
Check out what are trailling and rolling returns of this fund ?
View Detail Return Analysis1 Lac Users Opted for this Service
Free KYC Check
To know your eligibility for Mutual Fund Investment
Risk Analysis
Helps you understand the fund’s risk levels.
| Standard Dev | Sharpe | Beta | Alpha | |
|---|---|---|---|---|
| Fund | 0% | 0% | 0% | 0% |
| Category | 0% | 0% | 0% | 0% |
Riskometer
Comparison Of Kotak Healthcare Fund - Regular (G)
Compare your fund with the top category schemes.
Kotak Healthcare Fund - Regular (G)
3Y Returns0% (p.a.)
Quant Healthcare Fund Regular - Growth
3Y Returns0% (p.a.)
Kotak Healthcare Fund - Regular (G)
3Y Returns0% (p.a.)
DSP Healthcare Fund - Regular Plan - Growth
3Y Returns19.09% (p.a.)
Kotak Healthcare Fund - Regular (G)
3Y Returns0% (p.a.)
HDFC Pharma and Healthcare Fund - Regular (G)
3Y Returns0% (p.a.)
Kotak Healthcare Fund - Regular (G)
3Y Returns0% (p.a.)
ITI Pharma and Healthcare Fund Regular - Growth
3Y Returns0% (p.a.)
SIP Returns Calculator
A simple tool to calculate your SIP returns.
- Invested Amount
- Estimated Returns
- Future Value
Start small, dream big: Begin your journey to long-term wealth with SIPs starting at just ₹1000!
Start SIPPortfolio Summary (as on 30-Jun-2024)
An insight into your portfolio composition.
Equity98.36% Others3.31%
Equity Market Cap
Top 5 Sectors of Equity
Pharmaceuticals & Biotechnology 79.49%
Healthcare Services 17.64%
Insurance 1.23%
Top 5 Companies of Equity
Sun Pharmaceutical Industries Ltd. 15.02%
Cipla Ltd. 8.9%
Zydus Lifesciences Ltd. 6.25%
Max Healthcare Institute Ltd. 5.44%
Divis Laboratories Ltd. 5.38%
Others Market Cap
Top 5 Sectors of Others
3.31%
Top 5 Companies of Others
Triparty Repo 3.31%
Check out the favourite sectors and companies of this fund
Detail Portfolio AnalysisAlternative Fund Category Peer View
Check out the other Mutual Funds in this category
More Funds From Kotak Mutual Fund
| Scheme Name | 1M | 3M | 6M | 1Y | 5Y | |
|---|---|---|---|---|---|---|
| Kotak Nifty Next 50 Index Fund - Regular Plan - Growth Option | 2.35% | 9.61% | 28.46% | 68.79% | 0% | |
| KOTAK NIFTY 200 MOMENTUM 30 INDEX FUND REGULAR PLAN GROWTH | 2.04% | 7.05% | 24.3% | 65.73% | 0% | |
| Kotak Nifty Smallcap 50 Index Fund - Regular Plan - Growth | 3.77% | 16.96% | 24.25% | 64.78% | 0% | |
| KOTAK QUANT FUND REGULAR PLAN GROWTH | 0.2% | 9.07% | 17.12% | 57.53% | 0% | |
| Kotak Multicap Fund-Regular Plan-Growth | 1.71% | 13.67% | 21.71% | 55.25% | 0% | |
| Kotak India EQ Contra Fund - Growth | 1.37% | 11.19% | 21.88% | 54.12% | 24.9% |
Take test again
Chat with usFrequently Asked Questions
What is the current NAV of Kotak Healthcare Fund - Regular (G)?
Net asset value is the per unit price of the mutual fund. The NAV of funds changes every day. The latest NAV of Kotak Healthcare Fund - Regular (G) as of 31-10-2024 is 13.739.
What is the benchmark of Kotak Healthcare Fund - Regular (G)?
Kotak performance is primarily benchmarked against the NIFTY 500 TRI with NIFTY 50 TRI serving as an addition.
Is Kotak Healthcare Fund - Regular (G) a safe fund to invest?
Every fund has different types of risk which are mentioned in the risko-meter. The investors are advised to understand their risk tolerance and decide which type of fund they can invest in.
What are the top 5 holdings of Kotak Healthcare Fund - Regular (G)?
The fund's top 5 sectors holdings are Pharmaceuticals & Biotechnology, Healthcare Services, Insurance,
How can I redeem my investments in Kotak Healthcare Fund - Regular (G)?
Redeeming your investments in Kotak Healthcare Fund - Regular (G) is super easy.
• If you have invested this fund via MySIPonline, just log into the app, go to the investment section, and place your redemption request.
• If you have invested this fund from elsewhere, go to the fund house website and place your redemption request from there.
Who manages this fund, and what is their expertise?
Abhishek Bisen, Arjun Khanna, Shibani Sircar Kurian, Dhananjay Tikariha, with an extensive experience of 15 years while managing equity & related investments. He is focused on picking quality companies and holds them for a long duration to generate good compounding returns in their funds.
What is the expense ratio of Kotak Healthcare Fund - Regular (G)?
The expense ratio of a mutual fund means the charges that you pay to the mutual fund company for managing your investments in the fund. This fund has an expense ratio of 1.37%.
What is the AUM or size of Kotak Healthcare Fund - Regular (G)?
AUM or asset under management is the total value of the assets held by a mutual fund scheme. A fund with a high AUM means a lot of money has been invested in it. The AUM of Kotak Healthcare Fund - Regular (G) is Rs 0 Crs. Crs.
Should I invest in Kotak Healthcare Fund - Regular (G)?
This fund has a consistency rating of which indicates that the fund has generated average returns. However, whatever returns that the fund delivers, it does so with exceptional consistency. You can consider this fund if the predictability of returns is what you are looking for.
How to start online SIP in Kotak Healthcare Fund - Regular (G)s?
MySIPonline is a dedicated platform to start online SIP or mutual funds in any scheme of mutual funds. Firstly, the investor needs to complete KYC details, choose the best fund, add it to the cart, and make the payment through UPI, net banking, or debit card available on our site.
Is there any brokerage/advisory fees on Mutual Fund SIP transactions?
At MySIPonline, we do not charge any fees related to brokerage & advisory part. That makes us more accessible and cost-effective for a broader range of investors.
